Carolina Sotelo
Bogota, DC, Colombia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Alien Hand Syndrome as the Initial Presentation of Patent Foramen Ovale-Associated Stroke.
Journal: Clinical medicine insights. Case reports
Published: May 28, 2025
DICER1-associated central nervous system sarcoma: A comprehensive clinical and genomic characterization of case series of young adult patients.
Journal: Neuro-oncology practice
Published: July 17, 2023
Application of Comprehensive Genomic Profiling-Based Next-Generation Sequencing Assay to Improve Cancer Care in a Developing Country.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: May 06, 2023
Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study.
Journal: Targeted oncology
Published: February 19, 2023
STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 24, 2022
Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP).
Journal: Clinical lung cancer
Published: March 25, 2022
KRAS and MET in non-small-cell lung cancer: two of the new kids on the 'drivers' block.
Journal: Therapeutic advances in respiratory disease
Published: January 31, 2022
EGFR Inhibitors Plus Bevacizumab are Superior Than EGFR Inhibitors Alone as First-Line Setting in Advanced NSCLC With EGFR Mutations and BIM Deletion Polymorphisms (BIM-CLICaP).
Journal: JCO precision oncology
Published: January 07, 2022
Human papillomavirus infection and lung adenocarcinoma: special benefit is observed in patients treated with immune checkpoint inhibitors.
Journal: ESMO open
Published: December 15, 2021
p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among Hispanics.
Journal: Translational oncology
Published: November 01, 2021
Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation.
Journal: Journal of neuro-oncology
Published: July 08, 2021
Prognostic significance of telomerase reverse transcriptase promoter gen mutations in high grade meningiomas
Journal: Biomedica : revista del Instituto Nacional de Salud
Published: April 06, 2021
Last Updated: 09/26/2026